{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"ImageneBio, Inc."},"Symbol":{"label":"Symbol","value":"IMA"},"Address":{"label":"Address","value":"645 SUMMER STREET,SUITE 101, BOSTON, Massachusetts, 02210, United States"},"Phone":{"label":"Phone","value":"+1 857 273-8343"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"ImageneBio is a clinical-stage biotechnology company that boldly imagines a world where patients can be free from the burden of grievous immunological/autoimmune and inflammatory ('I&I') diseases. Imagene's purpose is to globally develop new medicines with differentiated profiles that can effectively control and change the course of I&I diseases for affected patients, treat their symptoms, and improve quality of life."},"CompanyUrl":{"label":"Company Url","value":"https://www.ikenaoncology.com"}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}